Ceesay Abraham (CIK 1722140) reported 39 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-08-12). Recent activity: Sell RAPP (14,171 shares), Sell RAPP (8,370 shares), Sell RAPP (3,664 shares), Sell RAPP (19,500 shares), Sell RAPP (5,794 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 14,171 | $651,492 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 8,370 | $391,280 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 3,664 | $171,837 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 19,500 | $936,846 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,794 | $281,721 |
| 2026-07-29 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,203 | $92,762 |
| 2026-07-29 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 7 | $299 |
| 2026-07-15 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,481 | $217,715 |
| 2026-07-15 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,729 | $110,722 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 7,344 | $292,062 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 876 | $35,336 |
| 2026-05-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 1,438 | $255,418 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 3,552 | $103,186 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,281 | $67,974 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,983 | $86,626 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,100 | $62,580 |
| 2026-01-22 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,833 | $152,358 |
| 2026-01-22 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,083 | $132,717 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,441 | $70,398 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,792 | $83,872 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 600 | $18,624 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,147 | $61,919 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,421 | $72,727 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 515 | $15,986 |
| 2025-11-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,777 | $69,203 |
Source: SEC Form 4 filings · as of 2026-08-12